866PDComprehensive biomarker analyses and updated results of PURE-01 study: Neoadjuvant pembrolizumab (pembro) in muscle-invasive urothelial bladder carcinoma (MIBC). (23rd October 2018) - Necchi, A; Briganti, A; Raggi, D; Luciano, R; Colecchia, M; Massa, S; Giannatempo, P; Colombo, R; Gallina, A; Salvioni, R; Mortarini, R; Montorsi, F; et al.